Synergy in polymicrobial infections in a mouse model of type 2 diabetes

Infection and Immunity

Volumn 73, Issue 9, 2005, Pages 6055-6063

  Mastropaolo, Matthew D ^a   Evans, Nicholas P ^a   Byrnes, Meghan K ^a   Stevens, Ann M ^a   Robertson, John L ^a   Melville, Stephen B ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAEROBIC BACTERIUM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTEROIDES FRAGILIS; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; LIMB AMPUTATION; LYMPHOCYTE COUNT; MICROBIAL COLONIZATION; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; SYSTEMIC DISEASE; WOUND HEALING;

ABSCESS; AGE FACTORS; ANIMALS; BACTEROIDES FRAGILIS; BACTEROIDES INFECTIONS; CLOSTRIDIUM INFECTIONS; CLOSTRIDIUM PERFRINGENS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; MICE; MICE, INBRED C57BL;

EID: 23944513876     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.9.6055-6063.2005     Document Type: Article

References (43)

1. Apelqvist, J., and J. Larsson. 2000. What is the most effective way to reduce incidence of amputation in the diabetic foot? Diabetes-Metab. Res. Rev. 16:S75-S83.
2. Bessman, A. N., F. L. Sapico, M. Tabatabai, and J. Z. Montgomerie. 1986. Persistence of polymicrobial abscesses in the poorly controlled diabetic host. Diabetes 35:448-453.
3. Bjornson, H. S., R. Colley, R. H. Bower, V. P. Duty, J. T. Schwartz-Fulton, and J. E. Fischer. 1982. Association between microorganism growth at the catheter insertion site and colonization of the catheter in patients receiving total parenteral nutrition. Surgery 92:720-727.
4. Boquet, P. 2001. The cytotoxic necrotizing factor 1 (CNF1) from Escherichia coli. Toxicon 39:1673-1680.
5. Brook, I. 1985. Enhancement of growth of aerobic and facultative bacteria in mixed infections with Bacteroides species. Infect. Immun. 50:929-931.
6. Brook, I. 1987. Synergistic aerobic and anaerobic infections. Clin. Ther. 10(Suppl. A):19-35.
7. Brook, I., J. C. Coolbaugh, and R. I. Walker. 1983. Antibiotic and clavulanic acid treatment of subcutaneous abscesses caused by Bacteroides fragilis alone or in combination with aerobic bacteria. J. Infect. Dis. 148:156-159.
8. Brook, I., V. Hunter, and R. I. Walker. 1984. Synergistic effect of bacteroides, Clostridium, Fusobacterium, anaerobic cocci, and aerobic bacteria on mortality and induction of subcutaneous abscesses in mice. J. Infect. Dis. 149:924-928.
9. Brook, I., and R. I. Walker. 1986. Pathogenicity of Clostridium species with other bacteria in mixed infections. J. Infect. 13:245-253.
10. Capo, C., S. Meconi, M. V. Sanguedolce, N. Bardin, G. Flatau, P. Boquet, and J. L. Mege. 1998. Effect of cytotoxic necrotizing factor-1 on actin cytoskeleton in human monocytes: role in the regulation of integrin-dependent phagocytosis. J. Immunol. 161:4301-4308.
11. Centers for Disease Control and Prevention. 2003. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2003. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, Ga.
12. Chen, H., O. Charlat, L. A. Tartaglia, E. A. Woolf, X. Weng, S. J. Ellis, N. D. Lakey, J. Culpepper, K. J. Moore, R. E. Breitbart, G. M. Duyk, R. I. Tepper, and J. P. Morgenstern. 1996. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84:491-495.
13. Comstock, L. E., M. J. Coyne, A. O. Tzianabos, A. Pantosti, A. B. Onderdonk, and D. L. Kasper. 1999. Analysis of a capsular polysaccharide biosynthesis locus of Bacteroides fragilis. Infect. Immun. 67:3525-3532.
14. Coyne, M. J., W. Kalka-Moll, A. O. Tzianabos, D. L. Kasper, and L. E. Comstock. 2000. Bacteroides fragilis NCTC9343 produces at least three distinct capsular polysaccharides: cloning, characterization, and reassignment of polysaccharide B and C biosynthesis loci. Infect. Immun. 68:6176-6181.
15. Coyne, M. J., A. O. Tzianabos, B. C. Mallory, V. J. Carey, D. L. Kasper, and L. E. Comstock. 2001. Polysaccharide biosynthesis locus required for virulence of Bacteroides fragilis. Infect. Immun. 69:4342-4350.
16. Fantuzzi, G., and R. Faggioni. 2000. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J. Leukoc. Biol. 68:437-446.
17. Flatau, G., E. Lemichez, M. Gauthier, P. Chardin, S. Paris, C. Fiorentini, and P. Boquet. 1997. Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature 387:729-733.
18. Fouad, A., J. Barry, J. Russo, J. Radolf, and Q. Zhu. 2002. Periapical lesion progression with controlled microbial inoculation in a type I diabetic mouse model. J. Endod. 28:8-16.
19. Gennis, R. B., and V. Stewart. 1996. Respiration, p. 217-261. In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella, 2nd ed. ASM Press, Washington, D.C.
20. Ginunas, V. J., H. N. Canawati, and F. L. Sapico. 1984. Anaerobic bacteria isolated from foot infections in diabetic patients: in vitro susceptibility to nine antibiotics. Clin. Ther. 6:457-460.
21. Hofman, P., G. Flatau, E. Selva, M. Gauthier, G. Le Negrate, C. Fiorentini, B. Rossi, and P. Boquet. 1998. Escherichia coli cytotoxic necrotizing factor 1 effaces microvilli and decreases transmigration of polymorphonuclear leukocytes in intestinal T84 epithelial cell monolayers. Infect. Immun. 66:2494-2500.
22. Hofman, P., G. Le Negrate, B. Mograbi, V. Hofman, P. Brest, A. Alliana-Schmid, G. Flatau, P. Boquet, and B. Rossi. 2000. Escherichia coli cytotoxic necrotizing factor-1 (CNF-1) increases the adherence to epithelia and the oxidative burst of human polymorphonuclear leukocytes but decreases bacteria phagocytosis. J. Leukoc. Biol. 68:522-528.
23. Ingham, H. R., P. R. Sisson, D. Tharagonnet, J. B. Selkon, and A. A. Codd. 1977. Inhibition of phagocytosis in vitro by obligate anaerobes. Lancet ii:1252-1254.
24. Johnson, J. L. 1978. Taxonomy of the Bacteroides. I. Deoxyribonucleic acid homologies among Bacteroides fragilis and other saccharolytic Bacteroides species. Int. J. Syst. Bacteriol. 28:245-268.
25. Kitahara, Y., T. Ishibashi, Y. Harada, M. Takamoto, and K. Tanaka. 1981. Reduced resistance to Pseudomonas septicaemia in diabetic mice. Clin. Exp. Immunol. 43:590-598.
26. Krinos, C. M., M. J. Coyne, K. G. Weinacht, A. O. Tzianabos, D. L. Kasper, and L. E. Comstock. 2001. Extensive surface diversity of a commensal microorganism by multiple DNA inversions. Nature 414:555-558.
27. Laing, P. 1998. The development and complications of diabetic foot ulcers. Am. J. Surg. 176:115-195.
28. Lerm, M., J. Selzer, A. Hoffmeyer, U. R. Rapp, K. Aktories, and G. Schmidt. 1999. Deamidation of Cdc42 and Rac by Escherichia coli cytotoxic necrotizing factor 1: activation of c-Jun N-terminal kinase in HeLa cells. Infect. Immun. 67:496-503.
29. Mahony, D. E., and T. I. Moore. 1976. Stable L-forms of Clostridium perfringens and their growth on glass surfaces. Can. J. Microbiol. 22:953-959.
30. Melville, S. B., R. Labbe, and A. L. Sonenshein. 1994. Expression from the Clostridium perfringens cpe promoter in C. perfringens and Bacillus subtilis. Infect. Immun. 62:5550-5558.
31. Menestrina, G., C. Moser, S. Pellet, and R. Welch. 1994. Pore-formation by Escherichia coli hemolysin (HIyA) and other members of the RTX toxins family. Toxicology 87:249-267.
32. Obana, Y., T. Nishino, and T. Tanino. 1985. Therapeutic efficacy of beta-lactam and aminoglycoside antibiotics on experimental pneumonia caused by Klebsiella pneumoniae B-54 in diabetic mice. J. Antibiot. (Tokyo) 38:941-947.
33. Obana, Y., K. Shibata, and T. Nishino. 1991. Adherence of Serratia marcescens in the pathogenesis of urinary tract infections in diabetic mice. J. Med. Microbiol. 35:93-97.
34. Onderdonk, A. B., D. L. Kasper, R. L. Cisneros, and J. G. Bartlett. 1977. The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains. J. Infect. Dis. 136:82-89.
35. Otto, B. R., M. Sparrius, A. M. Verweg-van Vught, and D. M. MacLaren. 1990. Iron-regulated outer membrane protein of Bacteroides fragilis involved in heme uptake. Infect. Immun. 58:3954-3958.
36. Rotstein, O. D., T. L. Pruett, and R. L. Simmons. 1985. Mechanisms of microbial synergy in polymicrobial surgical infections. Rev. Infect. Dis. 7:151-170.
37. Sapico, F. L., H. N. Canawati, J. L. Witte, J. Z. Montgomerie, F. W. Wagner, Jr., and A. N. Bessman. 1980. Quantitative aerobic and anaerobic bacteriology of infected diabetic feet. J. Clin. Microbiol. 12:413-420.
38. Sapico, F. L., J. L. Witte, H. N. Canawati, J. Z. Montgomerie, and A. N. Bessman. 1984. The infected foot of the diabetic patient: quantitative microbiology and analysis of clinical features. Rev. Infect. Dis. 6(Suppl. 1): S171-S176.
39. Schmidt, G., P. Sehr, M. Wilm, J. Selzer, M. Mann, and K. Aktories. 1997. Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. Nature 387:725-729.
40. Tzianabos, A. O., A. B. Onderdonk, B. Rosner, R. L. Cisneros, and D. L. Kasper. 1993. Structural features of polysaccharides that induce intra-abdominal abscesses. Science 262:416-419.
41. Ushijima, T., M. Takahashi, and A. Seto. 1990. The role of Escherichia coli haemolysin in the pathogenic synergy of colonic bacteria in subcutaneous abscess formation in mice. J. Med. Microbiol. 33:17-22.
42. Verweij-van Vught, A. M., F. Namavar, M. Sparrius, W. A. Vel, and D. M. MacLaren. 1985. Pathogenic synergy between Escherichia coli and Bacteroides fragilis: studies in an experimental mouse model. J. Med. Microbiol. 19:325-331.
43. Verweij-van Vught, A. M., F. Namavar, W. A. Vel, M. Sparrius, and D. M. MacLaren. 1986. Pathogenic synergy between Escherichia coli and Bacteroides fragilis or B. vulgatus in experimental infections: a nonspecific phenomenon. J. Med. Microbiol. 21:43-47.